Panel chair Philip Scheltens, MD, PhD, introduces the symposium’s topics, objectives, and expert panelists before briefly discussing the burden and current system constraints of the early diagnosis of Alzheimer’s disease. He then introduces a case study of a patient with the early stages of early-onset atypical Alzheimer’s disease, which will be followed throughout the symposia, from initial presentation to receiving a diagnosis.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.